Insulet (PODD) Financials

$255.47 +1.48 (+0.58%)

Closing price 04/14/2025 04:00 PM Eastern

Extended Trading

$254.42 -1.04 (-0.41%)

As of 09:20 AM Eastern

Annual Income Statements for Insulet

This table shows Insulet's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-74	-29	-27	3.30	12	6.80	17	4.60	206	418
Consolidated Net Income / (Loss)	-74	-29	-27	3.30	12	6.80	17	4.60	206	418
Net Income / (Loss) Continuing Operations	-62	-27	-27	3.30	12	6.80	17	4.60	206	418
Total Pre-Tax Income	-61	-27	-27	5.20	15	9.70	21	9.80	215	300
Total Operating Income	-49	-11	-7.40	27	50	52	126	38	220	309
Total Gross Profit	133	211	277	370	480	582	752	806	1,160	1,446
Total Revenue	264	367	464	564	738	904	1,099	1,305	1,697	2,072
Operating Revenue	264	367	464	564	738	904	1,099	1,305	1,697	2,072
Total Cost of Revenue	131	156	187	194	258	322	347	500	537	626
Operating Cost of Revenue	131	156	187	194	258	322	347	500	537	626
Total Operating Expenses	182	222	285	343	430	531	626	768	940	1,137
Selling, General & Admin Expense	60	72	85	248	298	384	466	588	735	917
Research & Development Expense	43	56	76	95	132	147	160	180	205	220
Total Other Income / (Expense), net	-13	-16	-19	-22	-36	-42	-106	-28	-5.40	-8.70
Interest Expense	13	17	22	21	36	45	104	36	36	43
Interest & Investment Income	-	-	-	-	-	-	0.50	9.30	29	40
Other Income / (Expense), net	0.06	0.83	2.60	-0.90	0.90	3.30	-1.90	-1.10	2.20	-5.50
Income Tax Expense	0.21	0.39	0.20	1.90	2.90	2.90	3.70	5.20	8.30	-118
Basic Earnings per Share	-	($0.48)	($0.46)	$0.06	$0.19	$0.11	$0.25	$0.07	$2.96	$5.97
Weighted Average Basic Shares Outstanding	56.79M	57.25M	58.00M	58.86M	60.59M	64.74M	67.70M	69.38M	69.75M	70.08M
Diluted Earnings per Share	-	($0.48)	($0.46)	$0.05	$0.19	$0.10	$0.24	$0.07	$2.94	$5.78
Weighted Average Diluted Shares Outstanding	56.79M	57.25M	58.00M	61.01M	62.30M	65.95M	68.58M	69.91M	73.63M	73.89M
Weighted Average Basic & Diluted Shares Outstanding	56.79M	57.25M	58.30M	-19.40M	62.86M	66.08M	69.22M	69.54M	69.93M	70.23M

This table shows Insulet's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-5.20	17	24	27	52	103	52	189	78	101
Consolidated Net Income / (Loss)	-5.20	17	24	27	52	103	52	189	78	101
Net Income / (Loss) Continuing Operations	-5.20	17	24	27	52	103	52	189	78	101
Total Pre-Tax Income	-5.70	22	25	29	54	108	55	51	83	111
Total Operating Income	2.90	24	28	31	55	106	57	55	88	109
Total Gross Profit	188	217	241	265	293	361	307	331	377	431
Total Revenue	341	370	358	397	433	510	442	489	544	598
Operating Revenue	341	370	358	397	433	510	442	489	544	598
Total Cost of Revenue	153	152	118	132	139	149	135	158	167	167
Operating Cost of Revenue	153	152	118	132	139	149	135	158	167	167
Total Operating Expenses	185	194	213	234	239	255	250	276	289	322
Selling, General & Admin Expense	140	144	163	179	181	213	200	222	234	261
Research & Development Expense	45	50	50	55	58	42	50	54	55	61
Total Other Income / (Expense), net	-8.60	-1.20	-3.10	-2.60	-1.10	1.40	-2.00	-3.50	-5.20	2.00
Interest Expense	9.20	9.60	9.40	9.70	10	6.70	11	11	12	8.70
Interest & Investment Income	2.40	-	6.50	7.30	8.60	6.20	9.40	9.30	11	10
Other Income / (Expense), net	-1.80	1.50	-0.20	-0.20	0.70	1.90	-0.70	-1.80	-3.40	0.40
Income Tax Expense	-0.50	5.30	0.80	1.20	1.80	4.50	3.40	-138	5.40	11
Basic Earnings per Share	($0.08)	$0.25	$0.34	$0.39	$0.74	$1.49	$0.74	$2.69	$1.11	$1.43
Weighted Average Basic Shares Outstanding	69.42M	69.38M	69.58M	69.74M	69.82M	69.75M	69.96M	70.06M	70.12M	70.08M
Diluted Earnings per Share	($0.08)	$0.25	$0.34	$0.39	$0.74	$1.47	$0.73	$2.59	$1.08	$1.38
Weighted Average Diluted Shares Outstanding	69.42M	69.91M	70.10M	70.14M	73.62M	73.63M	73.74M	73.80M	73.95M	73.89M
Weighted Average Basic & Diluted Shares Outstanding	69.45M	69.54M	69.70M	69.82M	69.83M	69.93M	70.04M	70.12M	70.14M	70.23M

This table details how cash moves in and out of Insulet's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-29	15	135	-159	100	708	-116	-117	15	249
Net Cash From Operating Activities	-13	16	41	36	98	84	-68	119	146	430
Net Cash From Continuing Operating Activities	-13	16	41	36	98	84	-68	119	146	427
Net Income / (Loss) Continuing Operations	-74	-29	-27	3.30	12	6.80	17	4.60	206	418
Consolidated Net Income / (Loss)	-74	-29	-27	3.30	12	6.80	17	4.60	206	418
Depreciation Expense	16	14	14	16	28	55	57	63	73	81
Amortization Expense	7.68	10	18	29	36	45	40	5.80	6.70	7.30
Non-Cash Adjustments To Reconcile Net Income	29	47	8.10	41	42	39	80	45	48	69
Changes in Operating Assets and Liabilities, net	8.00	-26	28	-53	-19	-63	-262	0.30	-188	-149
Net Cash From Investing Activities	-15	-178	-211	-185	-74	14	-83	-191	-119	-146
Net Cash From Continuing Investing Activities	-15	-178	-211	-185	-74	14	-83	-191	-119	-146
Purchase of Property, Plant & Equipment	-11	-22	-74	-157	-164	-167	-123	-136	-84	-134
Acquisitions	-4.72	-	-3.40	-5.00	-7.20	0.00	0.00	-48	-28	0.00
Purchase of Investments	0.00	-178	-298	-191	-151	-38	0.00	-7.80	-7.20	-12
Net Cash From Financing Activities	-0.37	177	305	-8.70	74	606	41	-40	-14	-28
Net Cash From Continuing Financing Activities	-0.37	177	305	-8.70	74	606	41	-40	-14	-28
Repayment of Debt	-5.58	-159	-99	-6.70	-664	66	-485	-20	-22	-56
Issuance of Debt	0.00	334	392	0.00	780	0.00	490	0.00	0.00	176
Issuance of Common Equity	7.85	4.85	16	0.00	4.30	484	8.10	9.40	11	12
Other Financing Activities, net	-2.65	-2.87	-4.10	-2.00	-47	56	28	-30	-1.90	-159
Effect of Exchange Rate Changes	-0.28	0.03	-	-1.40	1.50	4.80	-5.50	-4.30	1.80	-6.80

This table details how cash moves in and out of Insulet's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	13	-47	-54	24	25	19	47	70	82	51
Net Cash From Operating Activities	57	51	0.50	44	56	45	88	97	99	148
Net Cash From Continuing Operating Activities	57	51	0.50	44	57	44	88	97	99	144
Net Income / (Loss) Continuing Operations	-5.20	17	24	27	52	103	52	189	78	101
Consolidated Net Income / (Loss)	-5.20	17	24	27	52	103	52	189	78	101
Depreciation Expense	16	16	17	18	19	19	19	19	21	22
Amortization Expense	1.50	1.50	1.50	1.50	1.60	2.10	2.00	1.80	1.60	1.90
Non-Cash Adjustments To Reconcile Net Income	10	12	13	14	11	10	15	16	22	15
Changes in Operating Assets and Liabilities, net	34	3.70	-55	-17	-26	-90	-0.10	-130	-24	4.40
Net Cash From Investing Activities	-34	-88	-42	-23	-23	-32	-24	-25	-29	-68
Net Cash From Continuing Investing Activities	-34	-88	-42	-23	-23	-32	-24	-25	-29	-68
Purchase of Property, Plant & Equipment	-34	-67	-12	-18	-22	-32	-24	-25	-29	-56
Purchase of Investments	-	-	-2.00	-5.00	-0.20	-	0.00	-	-0.20	-12
Net Cash From Financing Activities	-3.90	-15	-12	3.20	-6.90	2.20	-14	-0.90	7.80	-21
Net Cash From Continuing Financing Activities	-3.90	-15	-12	3.20	-6.90	2.20	-14	-0.90	7.80	-21
Repayment of Debt	-4.90	-4.90	-5.40	-5.90	-5.50	-5.50	-7.80	-5.60	-27	-16
Issuance of Debt	-	-	-	-	-	-	-	-	-	13
Issuance of Common Equity	-	4.50	-	-	-	5.10	-	-	-	5.90
Other Financing Activities, net	1.00	-14	-6.70	3.60	-1.40	2.60	-6.30	-1.30	-128	-24
Effect of Exchange Rate Changes	-5.60	4.80	-0.10	0.10	-1.20	3.00	-2.50	-0.90	4.60	-8.00

This table presents Insulet's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	275	457	840	929	1,143	1,873	2,049	2,251	2,588	3,088
Total Current Assets	191	370	547	461	591	1,249	1,330	1,314	1,583	1,891
Cash & Equivalents	123	137	-	114	214	907	792	675	704	953
Accounts Receivable	43	29	5.12	77	69	95	161	206	360	366
Inventories, net	12	36	33	71	101	154	303	347	403	430
Prepaid Expenses	4.28	7.07	16	24	45	52	74	87	116	142
Plant, Property, & Equipment, net	42	45	0.00	258	399	479	537	600	665	723
Total Noncurrent Assets	43	42	15	209	153	146	183	337	340	473
Goodwill	40	40	-	40	40	40	40	52	52	52
Intangible Assets	0.93	2.04	-	10	13	29	37	76	99	99
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	-	1.80	142
Other Noncurrent Operating Assets	0.08	0.22	15	18	41	77	106	210	188	182
Total Liabilities & Shareholders' Equity	275	457	840	929	1,143	1,873	2,049	2,251	2,588	3,088
Total Liabilities	241	393	661	717	1,067	1,269	1,493	1,775	1,856	1,876
Total Current Liabilities	65	56	89	116	158	208	229	365	451	528
Short-Term Debt	5.52	-	-	-	0.00	16	25	28	49	84
Accounts Payable	15	13	-	26	55	54	38	31	19	20
Accrued Expenses	37	41	-	90	103	138	166	306	383	425
Total Noncurrent Liabilities	176	338	6.30	601	909	1,062	1,264	1,410	1,404	1,348
Long-Term Debt	172	333	-	592	888	1,044	1,249	1,374	1,366	1,296
Other Noncurrent Operating Liabilities	3.95	5.03	6.30	8.90	21	18	15	36	38	52
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	34	63	-687	212	76	604	556	476	733	1,212
Total Preferred & Common Equity	34	63	179	212	76	604	556	476	733	1,212
Preferred Stock	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	34	63	-687	212	76	604	556	476	733	1,212
Common Stock	686	744	-	899	749	1,264	1,208	1,041	1,103	1,185
Retained Earnings	-652	-680	-687	-684	-672	-666	-650	-584	-378	40
Accumulated Other Comprehensive Income / (Loss)	-0.65	-0.73	-	-2.90	-1.20	5.50	-2.20	20	8.00	-13

This table presents Insulet's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	2,166	2,251	2,289	2,386	2,468	2,588	2,624	2,882	3,025	3,088
Total Current Assets	1,329	1,314	1,330	1,422	1,471	1,583	1,618	1,749	1,861	1,891
Cash & Equivalents	722	675	621	660	685	704	751	821	903	953
Accounts Receivable	201	206	217	251	270	360	321	349	376	366
Inventories, net	328	347	386	411	411	403	431	431	445	430
Prepaid Expenses	78	87	106	100	105	116	116	148	138	142
Plant, Property, & Equipment, net	553	600	597	602	649	665	668	678	703	723
Total Noncurrent Assets	284	337	363	363	347	340	338	455	462	473
Goodwill	52	52	52	52	52	52	52	52	52	52
Intangible Assets	54	76	100	100	100	99	99	99	100	99
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	1.80	-	141	144	142
Other Noncurrent Operating Assets	179	210	211	212	196	188	188	164	166	182
Total Liabilities & Shareholders' Equity	2,166	2,251	2,289	2,386	2,468	2,588	2,624	2,882	3,025	3,088
Total Liabilities	1,738	1,775	1,786	1,832	1,860	1,856	1,833	1,883	1,907	1,876
Total Current Liabilities	334	365	383	425	451	451	432	486	506	528
Short-Term Debt	27	28	28	29	50	49	39	38	42	84
Accounts Payable	62	31	86	108	78	19	76	77	40	20
Accrued Expenses	245	306	270	288	324	383	318	371	424	425
Total Noncurrent Liabilities	1,404	1,410	1,403	1,407	1,409	1,404	1,401	1,397	1,401	1,348
Long-Term Debt	1,380	1,374	1,369	1,369	1,371	1,366	1,363	1,360	1,356	1,296
Other Noncurrent Operating Liabilities	24	36	34	38	38	38	38	37	45	52
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	428	476	503	554	608	733	791	998	1,118	1,212
Total Preferred & Common Equity	428	476	503	554	608	733	791	998	1,118	1,212
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	428	476	503	554	608	733	791	998	1,118	1,212
Common Stock	1,023	1,041	1,047	1,071	1,081	1,103	1,118	1,141	1,159	1,185
Retained Earnings	-601	-584	-561	-533	-481	-378	-327	-138	-60	40
Accumulated Other Comprehensive Income / (Loss)	6.80	20	16	16	7.60	8.00	-0.50	-4.40	20	-13

This table displays calculated financial ratios and metrics derived from Insulet's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.08%	39.07%	26.38%	21.56%	30.93%	22.51%	21.49%	18.79%	30.02%	22.07%
EBITDA Growth	-303.30%	155.73%	93.27%	163.47%	60.22%	35.84%	42.66%	-52.41%	185.97%	29.76%
EBIT Growth	-382.01%	79.71%	51.41%	652.08%	92.08%	7.66%	126.46%	-70.59%	508.77%	36.54%
NOPAT Growth	-449.20%	78.04%	30.87%	435.68%	130.04%	-9.74%	186.01%	-82.91%	1,098.32%	103.52%
Net Income Growth	-42.76%	60.72%	7.20%	112.31%	251.52%	-41.38%	147.06%	-72.62%	4,384.78%	102.76%
EPS Growth	0.00%	0.00%	4.17%	110.87%	280.00%	-47.37%	140.00%	-70.83%	4,100.00%	96.60%
Operating Cash Flow Growth	-240.72%	226.76%	159.57%	-13.08%	174.09%	-14.63%	-181.07%	274.74%	22.44%	195.33%
Free Cash Flow Firm Growth	-23.65%	-47.81%	257.69%	-968.13%	61.61%	-30.46%	-46.80%	33.08%	80.10%	907.34%
Invested Capital Growth	-18.89%	17.32%	-40.74%	549.00%	41.37%	35.14%	45.20%	15.88%	20.01%	13.42%
Revenue Q/Q Growth	35.15%	5.70%	6.18%	6.48%	6.42%	4.23%	5.94%	4.99%	9.00%	4.42%
EBITDA Q/Q Growth	-97.18%	227.08%	28.64%	21.10%	17.38%	-4.66%	22.83%	-22.03%	40.20%	1.01%
EBIT Q/Q Growth	-39.88%	47.15%	46.43%	58.37%	19.74%	-30.90%	80.38%	-39.97%	59.97%	0.46%
NOPAT Q/Q Growth	-39.44%	44.21%	31.19%	138.65%	-6.47%	-43.14%	113.79%	-65.59%	65.96%	-0.85%
Net Income Q/Q Growth	-42.50%	38.67%	7.87%	124.57%	-29.70%	-76.47%	156.95%	-72.62%	71.92%	-0.62%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	26.67%	-77.78%	153.33%	-72.00%	70.93%	-1.53%
Operating Cash Flow Q/Q Growth	-217.86%	169.93%	4.62%	31.25%	20.09%	-26.25%	-166.02%	178.04%	-3.64%	31.27%
Free Cash Flow Firm Q/Q Growth	-123.70%	37.95%	189.43%	-52.47%	-4.45%	-167.80%	15.07%	-9.30%	71.37%	45.26%
Invested Capital Q/Q Growth	-8.43%	-13.41%	-59.78%	7.88%	5.90%	15.50%	12.08%	8.16%	7.58%	1.51%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.50%	57.52%	59.77%	65.66%	65.06%	64.39%	68.45%	61.72%	68.35%	69.79%
EBITDA Margin	-9.53%	3.82%	5.84%	12.66%	15.50%	17.18%	20.18%	8.08%	17.78%	18.90%
Operating Margin	-18.47%	-2.92%	-1.60%	4.86%	6.77%	5.69%	11.47%	2.88%	12.96%	14.91%
EBIT Margin	-18.45%	-2.69%	-1.03%	4.70%	6.90%	6.06%	11.29%	2.80%	13.09%	14.65%
Profit (Net Income) Margin	-27.86%	-7.87%	-5.78%	0.59%	1.57%	0.75%	1.53%	0.35%	12.16%	20.19%
Tax Burden Percent	119.76%	107.69%	100.75%	63.46%	80.00%	70.10%	81.95%	46.94%	96.13%	139.34%
Interest Burden Percent	126.11%	271.46%	554.17%	19.62%	28.49%	17.70%	16.52%	26.85%	96.58%	98.95%
Effective Tax Rate	0.00%	0.00%	0.00%	36.54%	20.00%	29.90%	18.05%	53.06%	3.87%	-39.34%
Return on Invested Capital (ROIC)	-36.83%	-8.31%	-6.68%	8.05%	8.85%	5.80%	11.77%	1.57%	15.97%	27.93%
ROIC Less NNEP Spread (ROIC-NNEP)	-153.76%	-59.77%	-12.23%	4.94%	-0.37%	-4.57%	-17.34%	-0.58%	15.25%	25.80%
Return on Net Nonoperating Assets (RNNOA)	-87.91%	-51.11%	15.28%	-9.44%	-0.80%	-3.80%	-8.88%	-0.68%	18.15%	15.10%
Return on Equity (ROE)	-124.74%	-59.42%	8.59%	-1.39%	8.06%	2.00%	2.90%	0.89%	34.12%	43.03%
Cash Return on Invested Capital (CROIC)	-15.97%	-24.25%	44.48%	-138.55%	-25.43%	-24.09%	-25.09%	-13.14%	-2.21%	15.35%
Operating Return on Assets (OROA)	-17.01%	-2.70%	-0.74%	3.00%	4.91%	3.63%	6.33%	1.70%	9.18%	10.69%
Return on Assets (ROA)	-25.69%	-7.89%	-4.13%	0.37%	1.12%	0.45%	0.86%	0.21%	8.53%	14.74%
Return on Common Equity (ROCE)	-124.74%	-59.42%	8.59%	-1.39%	8.06%	2.00%	2.90%	0.89%	34.12%	43.03%
Return on Equity Simple (ROE_SIMPLE)	-215.91%	-45.73%	-14.98%	1.56%	15.28%	1.13%	3.02%	0.97%	28.16%	34.52%
Net Operating Profit after Tax (NOPAT)	-34	-7.49	-5.18	17	40	36	103	18	211	430
NOPAT Margin	-12.93%	-2.04%	-1.12%	3.08%	5.42%	3.99%	9.40%	1.35%	12.46%	20.78%
Net Nonoperating Expense Percent (NNEP)	116.94%	51.46%	5.55%	3.11%	9.23%	10.37%	29.11%	2.16%	0.72%	2.13%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	0.94%	9.84%	16.61%
Cost of Revenue to Revenue	49.50%	42.48%	40.23%	34.34%	34.94%	35.61%	31.55%	38.28%	31.65%	30.21%
SG&A Expenses to Revenue	22.89%	19.51%	18.26%	43.99%	40.37%	42.46%	42.41%	45.03%	43.30%	44.28%
R&D to Revenue	16.37%	15.18%	16.32%	16.81%	17.92%	16.23%	14.57%	13.81%	12.08%	10.60%
Operating Expenses to Revenue	68.97%	60.44%	61.36%	60.80%	58.29%	58.69%	56.98%	58.84%	55.38%	54.88%
Earnings before Interest and Taxes (EBIT)	-49	-9.88	-4.80	27	51	55	124	37	222	303
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-25	14	27	71	114	155	222	106	302	392
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	63.21	34.26	0.00	22.09	139.44	27.92	32.99	42.92	20.68	15.11
Price to Tangible Book Value (P/TBV)	0.00	100.96	0.00	28.91	462.18	31.50	38.24	58.55	26.02	17.25
Price to Revenue (P/Rev)	8.16	5.90	8.66	8.31	14.34	18.63	16.70	15.66	8.93	8.84
Price to Earnings (P/E)	0.00	0.00	0.00	1,420.00	912.40	2,478.40	1,092.27	4,444.57	73.44	43.78
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.07%	0.11%	0.04%	0.09%	0.02%	1.36%	2.28%
Enterprise Value to Invested Capital (EV/IC)	26.60	22.58	69.60	12.95	20.85	23.72	18.13	17.59	10.98	11.44
Enterprise Value to Revenue (EV/Rev)	8.36	5.99	8.66	8.60	14.95	18.76	17.14	16.22	9.35	9.05
Enterprise Value to EBITDA (EV/EBITDA)	0.00	156.75	148.15	67.90	96.48	109.17	84.95	200.68	52.58	47.87
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	182.96	216.84	309.58	151.75	580.06	71.39	61.76
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	278.82	275.93	469.90	182.38	1,199.62	75.00	43.54
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	138.14	97.21	135.05	112.17	201.96	0.00	177.92	108.87	43.55
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	116.45	0.00	0.00	0.00	0.00	0.00	0.00	79.19
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.21	5.27	0.00	2.79	11.70	1.76	2.29	2.94	1.93	1.14
Long-Term Debt to Equity	5.05	5.27	0.00	2.79	11.70	1.73	2.24	2.88	1.86	1.07
Financial Leverage	0.57	0.86	-1.25	-1.91	2.14	0.83	0.51	1.17	1.19	0.59
Leverage Ratio	4.86	7.53	-2.08	-3.73	7.19	4.44	3.38	4.16	4.00	2.92
Compound Leverage Factor	6.12	20.44	-11.52	-0.73	2.05	0.79	0.56	1.12	3.87	2.89
Debt to Total Capital	83.90%	84.05%	0.00%	73.62%	92.12%	63.70%	69.60%	74.64%	65.90%	53.25%
Short-Term Debt to Total Capital	2.61%	0.00%	0.00%	0.00%	0.00%	0.94%	1.37%	1.46%	2.30%	3.23%
Long-Term Debt to Total Capital	81.29%	84.05%	0.00%	73.62%	92.12%	62.76%	68.23%	73.17%	63.60%	50.01%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	16.10%	15.95%	100.00%	26.38%	7.88%	36.30%	30.40%	25.36%	34.10%	46.75%
Debt to EBITDA	-7.05	23.73	0.00	8.29	7.76	6.82	5.75	13.29	4.69	3.52
Net Debt to EBITDA	-2.18	2.44	0.00	2.27	3.96	0.72	2.18	6.89	2.36	1.09
Long-Term Debt to EBITDA	-6.83	23.73	0.00	8.29	7.76	6.72	5.63	13.03	4.53	3.31
Debt to NOPAT	-5.20	-44.41	0.00	34.05	22.20	29.34	12.34	79.43	6.69	3.21
Net Debt to NOPAT	-1.61	-4.56	0.00	9.33	11.34	3.09	4.67	41.20	3.36	0.99
Long-Term Debt to NOPAT	-5.04	-44.41	0.00	34.05	22.20	28.91	12.09	77.87	6.46	3.01
Altman Z-Score	2.96	2.77	3.69	4.04	6.38	8.71	8.31	7.69	6.16	7.40
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.93	6.64	6.17	3.99	3.75	6.01	5.81	3.60	3.51	3.58
Quick Ratio	2.54	5.88	0.06	3.16	2.82	5.02	4.16	2.41	2.36	2.50
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-15	-22	34	-299	-115	-150	-220	-147	-29	237
Operating Cash Flow to CapEx	-118.33%	71.95%	55.96%	22.81%	60.11%	50.45%	-55.50%	87.63%	173.25%	321.12%
Free Cash Flow to Firm to Interest Expense	-1.16	-1.29	1.58	-14.05	-3.16	-3.32	-2.11	-4.09	-0.81	5.54
Operating Cash Flow to Interest Expense	-0.99	0.94	1.89	1.69	2.70	1.86	-0.65	3.31	4.02	10.08
Operating Cash Flow Less CapEx to Interest Expense	-1.82	-0.37	-1.49	-5.70	-1.79	-1.83	-1.83	-0.47	1.70	6.94
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.92	1.00	0.72	0.64	0.71	0.60	0.56	0.61	0.70	0.73
Accounts Receivable Turnover	6.40	10.29	27.35	13.78	10.11	10.99	8.57	7.12	6.00	5.71
Inventory Turnover	10.40	6.56	5.44	3.71	2.99	2.52	1.52	1.54	1.43	1.50
Fixed Asset Turnover	6.69	8.48	0.00	0.00	2.24	2.06	2.16	2.30	2.68	2.99
Accounts Payable Turnover	8.75	10.99	0.00	0.00	6.45	5.93	7.55	14.59	21.49	32.10
Days Sales Outstanding (DSO)	56.99	35.47	13.35	26.48	36.09	33.21	42.57	51.26	60.79	63.89
Days Inventory Outstanding (DIO)	35.10	55.65	67.05	98.45	122.00	144.65	240.82	237.39	254.59	242.89
Days Payable Outstanding (DPO)	41.74	33.21	0.00	0.00	56.61	61.53	48.32	25.02	16.99	11.37
Cash Conversion Cycle (CCC)	50.36	57.91	80.40	124.94	101.48	116.33	235.07	263.63	298.39	295.40
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	83	97	58	374	529	715	1,039	1,204	1,444	1,638
Invested Capital Turnover	2.85	4.07	5.98	2.61	1.63	1.45	1.25	1.16	1.28	1.34
Increase / (Decrease) in Invested Capital	-19	14	-40	317	155	186	323	165	241	194
Enterprise Value (EV)	2,207	2,198	4,015	4,848	11,037	16,965	18,832	21,172	15,863	18,739
Market Capitalization	2,152	2,164	4,015	4,686	10,584	16,853	18,350	20,445	15,151	18,313
Book Value per Share	$0.60	$1.10	($11.81)	$3.59	$1.23	$9.16	$8.07	$6.86	$10.49	$17.27
Tangible Book Value per Share	($0.11)	$0.37	($11.81)	$2.74	$0.37	$8.12	$6.96	$5.03	$8.34	$15.13
Total Capital	212	396	-687	804	964	1,663	1,830	1,878	2,149	2,592
Total Debt	177	333	0.00	592	888	1,059	1,274	1,402	1,416	1,380
Total Long-Term Debt	172	333	0.00	592	888	1,044	1,249	1,374	1,366	1,296
Net Debt	55	34	0.00	162	453	112	482	727	712	427
Capital Expenditures (CapEx)	11	22	74	157	164	167	123	136	84	134
Debt-free, Cash-free Net Working Capital (DFCFNWC)	8.45	16	458	57	57	109	335	302	477	493
Debt-free Net Working Capital (DFNWC)	131	314	458	346	433	1,057	1,126	977	1,181	1,447
Net Working Capital (NWC)	126	314	458	346	433	1,041	1,101	949	1,132	1,363
Net Nonoperating Expense (NNE)	39	21	22	14	28	29	86	13	5.19	12
Net Nonoperating Obligations (NNO)	49	34	745	162	453	112	482	727	712	427
Total Depreciation and Amortization (D&A)	24	24	32	45	64	101	98	69	80	88
Debt-free, Cash-free Net Working Capital to Revenue	3.20%	4.28%	98.85%	10.06%	7.75%	12.04%	30.44%	23.14%	28.10%	23.81%
Debt-free Net Working Capital to Revenue	49.69%	85.63%	98.85%	61.30%	58.70%	116.82%	102.48%	74.83%	69.60%	69.83%
Net Working Capital to Revenue	47.60%	85.63%	98.85%	61.30%	58.70%	115.09%	100.20%	72.73%	66.68%	65.79%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.29)	$0.00	$0.00	$0.06	$0.19	$0.11	$0.25	$0.07	$2.96	$5.97
Adjusted Weighted Average Basic Shares Outstanding	57.02M	57.65M	58.39M	58.86M	60.59M	64.74M	67.70M	69.38M	69.75M	70.08M
Adjusted Diluted Earnings per Share	($1.29)	$0.00	$0.00	$0.05	$0.19	$0.10	$0.24	$0.07	$2.94	$5.78
Adjusted Weighted Average Diluted Shares Outstanding	57.02M	57.65M	58.39M	61.01M	62.30M	65.95M	68.58M	69.91M	73.63M	73.89M
Adjusted Basic & Diluted Earnings per Share	($1.29)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.79M	57.25M	58.00M	59.28M	62.86M	66.08M	69.22M	69.54M	69.93M	70.23M
Normalized Net Operating Profit after Tax (NOPAT)	-34	-7.49	-5.18	17	40	36	103	26	211	216
Normalized NOPAT Margin	-12.93%	-2.04%	-1.12%	3.08%	5.42%	3.99%	9.40%	2.02%	12.46%	10.44%
Pre Tax Income Margin	-23.26%	-7.31%	-5.74%	0.92%	1.96%	1.07%	1.87%	0.75%	12.65%	14.49%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.83	-0.58	-0.22	1.24	1.40	1.22	1.19	1.01	6.14	7.11
NOPAT to Interest Expense	-2.68	-0.44	-0.24	0.82	1.10	0.80	0.99	0.49	5.84	10.08
EBIT Less CapEx to Interest Expense	-4.66	-1.89	-3.61	-6.15	-3.10	-2.48	0.01	-2.76	3.81	3.97
NOPAT Less CapEx to Interest Expense	-3.52	-1.75	-3.62	-6.57	-3.40	-2.89	-0.19	-3.28	3.52	6.94
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Insulet's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	23.66%	20.15%	21.23%	32.43%	26.97%	37.90%	23.35%	23.20%	25.70%	17.20%
EBITDA Growth	-66.91%	-41.10%	-16.00%	571.96%	309.73%	202.58%	66.67%	46.14%	41.95%	3.02%
EBIT Growth	-96.67%	-49.29%	-28.01%	211.15%	4,945.45%	333.20%	104.36%	70.87%	52.61%	1.29%
NOPAT Growth	-92.73%	-58.77%	-25.47%	259.39%	2,509.02%	469.13%	99.17%	576.45%	55.51%	-3.01%
Net Income Growth	-141.27%	-41.78%	-14.39%	178.00%	1,098.08%	507.65%	116.39%	590.84%	49.33%	-2.52%
EPS Growth	-144.44%	-41.86%	-15.00%	178.00%	1,025.00%	488.00%	114.71%	564.10%	45.95%	-6.12%
Operating Cash Flow Growth	319.77%	298.82%	103.65%	73.91%	-1.23%	-10.85%	17,420.00%	119.32%	75.89%	226.77%
Free Cash Flow Firm Growth	34.17%	47.48%	69.23%	54.63%	3.88%	5.54%	-11.95%	39.87%	-6.79%	31.64%
Invested Capital Growth	20.07%	15.88%	10.75%	14.78%	20.65%	20.01%	12.69%	21.96%	20.20%	13.42%
Revenue Q/Q Growth	13.83%	8.48%	-3.14%	10.72%	9.13%	17.82%	-13.36%	10.60%	11.34%	9.85%
EBITDA Q/Q Growth	272.90%	130.81%	8.20%	9.31%	50.10%	70.45%	-40.40%	-4.16%	45.80%	23.70%
EBIT Q/Q Growth	103.96%	2,172.73%	10.00%	12.36%	79.61%	95.14%	-48.11%	-6.05%	60.42%	29.52%
NOPAT Q/Q Growth	110.86%	782.50%	49.59%	11.16%	77.79%	92.51%	-47.65%	277.54%	-59.13%	20.07%
Net Income Q/Q Growth	85.14%	426.92%	40.00%	14.71%	90.11%	99.04%	-50.15%	266.21%	-58.91%	29.94%
EPS Q/Q Growth	84.00%	412.50%	36.00%	14.71%	89.74%	98.65%	-50.34%	254.79%	-58.30%	27.78%
Operating Cash Flow Q/Q Growth	124.11%	-10.58%	-99.01%	8,700.00%	27.27%	-19.29%	93.81%	10.16%	2.07%	49.95%
Free Cash Flow Firm Q/Q Growth	38.86%	20.10%	33.80%	-40.30%	-29.54%	21.49%	21.55%	24.64%	-130.06%	49.74%
Invested Capital Q/Q Growth	-1.12%	8.16%	6.25%	1.01%	3.94%	7.58%	-0.23%	9.31%	2.44%	1.51%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.25%	58.78%	67.16%	66.81%	67.78%	70.85%	69.46%	67.74%	69.33%	72.12%
EBITDA Margin	5.43%	11.55%	12.90%	12.74%	17.52%	25.34%	17.43%	15.11%	19.78%	22.28%
Operating Margin	0.85%	6.36%	7.74%	7.84%	12.66%	20.87%	12.88%	11.18%	16.20%	18.29%
EBIT Margin	0.32%	6.76%	7.68%	7.79%	12.83%	21.24%	12.72%	10.81%	15.57%	18.36%
Profit (Net Income) Margin	-1.53%	4.60%	6.65%	6.89%	11.99%	20.26%	11.66%	38.61%	14.25%	16.85%
Tax Burden Percent	91.23%	76.23%	96.75%	95.79%	96.65%	95.83%	93.81%	369.08%	93.49%	90.48%
Interest Burden Percent	-518.18%	89.20%	89.45%	92.23%	96.76%	99.54%	97.69%	96.78%	97.87%	101.46%
Effective Tax Rate	0.00%	23.77%	3.25%	4.21%	3.35%	4.17%	6.19%	-269.08%	6.51%	9.52%
Return on Invested Capital (ROIC)	0.73%	5.64%	8.41%	9.11%	15.52%	25.64%	15.82%	53.90%	20.32%	22.25%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.57%	5.49%	8.01%	8.76%	15.37%	25.82%	15.56%	51.93%	19.53%	22.56%
Return on Net Nonoperating Assets (RNNOA)	-0.69%	6.43%	12.52%	12.93%	21.08%	30.73%	17.16%	43.97%	13.93%	13.21%
Return on Equity (ROE)	0.04%	12.07%	20.93%	22.04%	36.60%	56.37%	32.98%	97.87%	34.26%	35.45%
Cash Return on Invested Capital (CROIC)	-13.21%	-13.14%	-9.94%	-7.40%	-8.34%	-2.21%	5.57%	8.33%	11.02%	15.35%
Operating Return on Assets (OROA)	0.19%	4.11%	4.82%	5.08%	8.62%	14.90%	9.22%	7.69%	11.25%	13.40%
Return on Assets (ROA)	-0.91%	2.79%	4.17%	4.48%	8.06%	14.21%	8.45%	27.45%	10.29%	12.30%
Return on Common Equity (ROCE)	0.04%	12.07%	20.93%	22.04%	36.60%	56.37%	32.98%	97.87%	34.26%	35.45%
Return on Equity Simple (ROE_SIMPLE)	3.93%	0.00%	0.12%	11.36%	19.75%	0.00%	29.59%	39.59%	37.65%	0.00%
Net Operating Profit after Tax (NOPAT)	2.03	18	27	30	53	102	53	202	82	99
NOPAT Margin	0.60%	4.85%	7.48%	7.51%	12.24%	20.00%	12.08%	41.25%	15.14%	16.55%
Net Nonoperating Expense Percent (NNEP)	1.30%	0.15%	0.40%	0.35%	0.15%	-0.19%	0.26%	1.97%	0.79%	-0.32%
Return On Investment Capital (ROIC_SIMPLE)	-	0.95%	-	-	-	4.75%	-	-	-	3.82%
Cost of Revenue to Revenue	44.75%	41.22%	32.84%	33.19%	32.22%	29.15%	30.54%	32.26%	30.67%	27.88%
SG&A Expenses to Revenue	41.20%	39.03%	45.43%	45.07%	41.76%	41.74%	45.21%	45.53%	43.04%	43.68%
R&D to Revenue	13.20%	13.39%	13.99%	13.90%	13.36%	8.24%	11.37%	11.03%	10.09%	10.14%
Operating Expenses to Revenue	54.40%	52.42%	59.42%	58.97%	55.12%	49.98%	56.58%	56.56%	53.13%	53.82%
Earnings before Interest and Taxes (EBIT)	1.10	25	28	31	56	108	56	53	85	110
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	19	43	46	51	76	129	77	74	108	133
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	37.20	42.92	44.12	36.28	18.33	20.68	15.14	14.16	14.60	15.11
Price to Tangible Book Value (P/TBV)	49.34	58.55	63.21	49.90	24.40	26.02	18.69	16.66	16.88	17.25
Price to Revenue (P/Rev)	12.81	15.66	16.21	13.72	7.15	8.93	6.72	7.55	8.23	8.84
Price to Earnings (P/E)	947.69	4,444.57	36,968.66	319.49	92.80	73.44	51.15	35.76	38.77	43.78
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.11%	0.02%	0.00%	0.31%	1.08%	1.36%	1.96%	2.80%	2.58%	2.28%
Enterprise Value to Invested Capital (EV/IC)	14.92	17.59	17.95	16.13	8.84	10.98	8.76	9.34	10.42	11.44
Enterprise Value to Revenue (EV/Rev)	13.36	16.22	16.78	14.22	7.62	9.35	7.09	7.86	8.48	9.05
Enterprise Value to EBITDA (EV/EBITDA)	122.73	200.68	237.41	131.94	55.16	52.58	37.95	41.35	43.38	47.87
Enterprise Value to EBIT (EV/EBIT)	273.12	580.06	889.81	246.55	85.46	71.39	50.29	53.93	55.68	61.76
Enterprise Value to NOPAT (EV/NOPAT)	323.80	1,199.62	7,121.73	270.96	93.15	75.00	53.00	36.50	38.74	43.54
Enterprise Value to Operating Cash Flow (EV/OCF)	387.99	177.92	172.35	137.15	78.51	108.87	54.20	51.56	51.30	43.55
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	166.46	123.22	103.23	79.19
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	3.29	2.94	2.78	2.52	2.34	1.93	1.77	1.40	1.25	1.14
Long-Term Debt to Equity	3.22	2.88	2.72	2.47	2.26	1.86	1.72	1.36	1.21	1.07
Financial Leverage	1.20	1.17	1.56	1.48	1.37	1.19	1.10	0.85	0.71	0.59
Leverage Ratio	4.50	4.16	4.59	4.61	4.48	4.00	3.80	3.39	3.18	2.92
Compound Leverage Factor	-23.31	3.71	4.11	4.25	4.33	3.98	3.71	3.28	3.12	2.96
Debt to Total Capital	76.67%	74.64%	73.53%	71.62%	70.04%	65.90%	63.93%	58.33%	55.57%	53.25%
Short-Term Debt to Total Capital	1.47%	1.46%	1.46%	1.50%	2.46%	2.30%	1.77%	1.58%	1.67%	3.23%
Long-Term Debt to Total Capital	75.21%	73.17%	72.06%	70.12%	67.59%	63.60%	62.16%	56.75%	53.90%	50.01%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	23.33%	25.36%	26.47%	28.38%	29.96%	34.10%	36.07%	41.67%	44.43%	46.75%
Debt to EBITDA	10.40	13.29	14.44	8.85	6.60	4.69	4.22	3.93	3.61	3.52
Net Debt to EBITDA	5.06	6.89	8.02	4.67	3.42	2.36	1.96	1.62	1.28	1.09
Long-Term Debt to EBITDA	10.20	13.03	14.16	8.67	6.37	4.53	4.10	3.82	3.50	3.31
Debt to NOPAT	27.43	79.43	433.25	18.18	11.15	6.69	5.89	3.47	3.22	3.21
Net Debt to NOPAT	13.35	41.20	240.70	9.59	5.77	3.36	2.73	1.43	1.14	0.99
Long-Term Debt to NOPAT	26.91	77.87	424.63	17.80	10.76	6.46	5.72	3.37	3.12	3.01
Altman Z-Score	6.23	7.67	8.24	7.43	4.52	6.01	5.03	5.67	6.39	7.19
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.98	3.60	3.47	3.34	3.26	3.51	3.74	3.60	3.68	3.58
Quick Ratio	2.76	2.41	2.19	2.14	2.12	2.36	2.48	2.41	2.53	2.50
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-184	-147	-97	-137	-177	-139	-109	-82	-189	-95
Operating Cash Flow to CapEx	167.26%	75.78%	4.17%	243.09%	250.00%	143.04%	365.00%	387.55%	338.49%	263.75%
Free Cash Flow to Firm to Interest Expense	-20.00	-15.31	-10.35	-14.07	-17.00	-20.72	-10.18	-7.46	-15.35	-10.91
Operating Cash Flow to Interest Expense	6.16	5.28	0.05	4.54	5.38	6.75	8.19	8.77	8.01	16.98
Operating Cash Flow Less CapEx to Interest Expense	2.48	-1.69	-1.22	2.67	3.23	2.03	5.94	6.51	5.64	10.54
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.60	0.61	0.63	0.65	0.67	0.70	0.72	0.71	0.72	0.73
Accounts Receivable Turnover	7.88	7.12	6.73	6.41	6.60	6.00	6.62	6.25	6.14	5.71
Inventory Turnover	1.51	1.54	1.52	1.51	1.47	1.43	1.36	1.38	1.42	1.50
Fixed Asset Turnover	2.33	2.30	2.41	2.58	2.59	2.68	2.82	2.93	2.93	2.99
Accounts Payable Turnover	7.36	14.59	7.70	6.73	7.73	21.49	6.85	6.30	10.29	32.10
Days Sales Outstanding (DSO)	46.34	51.26	54.23	56.94	55.29	60.79	55.11	58.38	59.42	63.89
Days Inventory Outstanding (DIO)	242.31	237.39	240.62	240.99	249.09	254.59	268.80	264.77	256.89	242.89
Days Payable Outstanding (DPO)	49.61	25.02	47.41	54.25	47.19	16.99	53.25	57.94	35.46	11.37
Cash Conversion Cycle (CCC)	239.04	263.63	247.44	243.69	257.19	298.39	270.65	265.22	280.85	295.40
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,113	1,204	1,279	1,292	1,343	1,444	1,441	1,575	1,614	1,638
Invested Capital Turnover	1.22	1.16	1.12	1.21	1.27	1.28	1.31	1.31	1.34	1.34
Increase / (Decrease) in Invested Capital	186	165	124	166	230	241	162	284	271	194
Enterprise Value (EV)	16,606	21,172	22,957	20,834	11,871	15,863	12,619	14,711	16,815	18,739
Market Capitalization	15,921	20,445	22,181	20,096	11,136	15,151	11,968	14,134	16,319	18,313
Book Value per Share	$6.17	$6.86	$7.23	$7.95	$8.70	$10.49	$11.30	$14.25	$15.95	$17.27
Tangible Book Value per Share	$4.65	$5.03	$5.05	$5.78	$6.54	$8.34	$9.16	$12.11	$13.79	$15.13
Total Capital	1,835	1,878	1,899	1,952	2,028	2,149	2,192	2,396	2,516	2,592
Total Debt	1,407	1,402	1,397	1,398	1,420	1,416	1,402	1,398	1,398	1,380
Total Long-Term Debt	1,380	1,374	1,369	1,369	1,371	1,366	1,363	1,360	1,356	1,296
Net Debt	685	727	776	738	735	712	650	577	496	427
Capital Expenditures (CapEx)	34	67	12	18	22	32	24	25	29	56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	300	302	354	366	384	477	474	480	494	493
Debt-free Net Working Capital (DFNWC)	1,022	977	975	1,026	1,070	1,181	1,225	1,301	1,397	1,447
Net Working Capital (NWC)	995	949	947	997	1,020	1,132	1,186	1,263	1,355	1,363
Net Nonoperating Expense (NNE)	7.23	0.91	3.00	2.49	1.06	-1.34	1.88	13	4.86	-1.81
Net Nonoperating Obligations (NNO)	685	727	776	738	735	712	650	577	496	427
Total Depreciation and Amortization (D&A)	17	18	19	20	20	21	21	21	23	23
Debt-free, Cash-free Net Working Capital to Revenue	24.11%	23.14%	25.86%	24.95%	24.67%	28.10%	26.60%	25.62%	24.91%	23.81%
Debt-free Net Working Capital to Revenue	82.18%	74.83%	71.24%	70.01%	68.69%	69.60%	68.79%	69.46%	70.40%	69.83%
Net Working Capital to Revenue	80.02%	72.73%	69.20%	68.02%	65.49%	66.68%	66.60%	67.43%	68.28%	65.79%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.08)	$0.25	$0.34	$0.39	$0.74	$1.49	$0.74	$2.69	$1.11	$1.43
Adjusted Weighted Average Basic Shares Outstanding	69.42M	69.38M	69.58M	69.74M	69.82M	69.75M	69.96M	70.06M	70.12M	70.08M
Adjusted Diluted Earnings per Share	($0.08)	$0.25	$0.34	$0.39	$0.74	$1.47	$0.73	$2.59	$1.08	$1.38
Adjusted Weighted Average Diluted Shares Outstanding	69.42M	69.91M	70.10M	70.14M	73.62M	73.63M	73.74M	73.80M	73.95M	73.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	69.45M	69.54M	69.70M	69.82M	69.83M	69.93M	70.04M	70.12M	70.14M	70.23M
Normalized Net Operating Profit after Tax (NOPAT)	2.03	18	27	30	53	102	53	38	82	99
Normalized NOPAT Margin	0.60%	4.85%	7.48%	7.51%	12.24%	20.00%	12.08%	7.82%	15.14%	16.55%
Pre Tax Income Margin	-1.67%	6.03%	6.87%	7.19%	12.41%	21.15%	12.43%	10.46%	15.24%	18.63%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.12	2.60	2.93	3.19	5.34	16.16	5.25	4.80	6.89	12.61
NOPAT to Interest Expense	0.22	1.87	2.85	3.07	5.09	15.22	4.99	18.32	6.70	11.37
EBIT Less CapEx to Interest Expense	-3.57	-4.36	1.65	1.32	3.18	11.45	3.01	2.54	4.52	6.17
NOPAT Less CapEx to Interest Expense	-3.46	-5.10	1.57	1.21	2.94	10.50	2.75	16.06	4.33	4.93
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Insulet's Financials

When does Insulet's fiscal year end?

According to the most recent income statement we have on file, Insulet's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Insulet's net income changed over the last 9 years?

Insulet's net income appears to be on an upward trend, with a most recent value of $418.30 million in 2024, falling from -$73.52 million in 2015. The previous period was $206.30 million in 2023.

What is Insulet's operating income?

Insulet's total operating income in 2024 was $308.90 million, based on the following breakdown:

Total Gross Profit: $1.45 billion
Total Operating Expenses: $1.14 billion

How has Insulet revenue changed over the last 9 years?

Over the last 9 years, Insulet's total revenue changed from $263.89 million in 2015 to $2.07 billion in 2024, a change of 685.0%.

How much debt does Insulet have?

Insulet's total liabilities were at $1.88 billion at the end of 2024, a 1.1% increase from 2023, and a 678.2% increase since 2015.

How much cash does Insulet have?

In the past 9 years, Insulet's cash and equivalents has ranged from $0.00 in 2017 to $953.40 million in 2024, and is currently $953.40 million as of their latest financial filing in 2024.

How has Insulet's book value per share changed over the last 9 years?

Over the last 9 years, Insulet's book value per share changed from 0.60 in 2015 to 17.27 in 2024, a change of 2,787.9%.

Remove Ads

Related Companies

This page (NASDAQ:PODD) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Insulet (PODD) Financials

Frequently Asked Questions About Insulet's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Insulet (PODD) Financials

Annual Income Statements for Insulet

Quarterly Income Statements for Insulet

Annual Cash Flow Statements for Insulet

Quarterly Cash Flow Statements for Insulet

Annual Balance Sheets for Insulet

Quarterly Balance Sheets for Insulet

Annual Metrics and Ratios for Insulet

Quarterly Metrics and Ratios for Insulet

Frequently Asked Questions About Insulet's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools